Clinical Trial Update: Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation [NA]

View source ↗

Summary

This clinical trial evaluated busulfan monotherapy as conditioning for autologous hematopoietic progenitor cell transplantation in acute myeloid leukemia and ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Acute Myeloid Leukemia (AML) | NA | Status: TERMINATED | Results posted: 2011-09-30